Biogen (BIIB) Gross Margin (2009 - 2026)
Biogen (BIIB) posted quarterly Gross Margin of 71.6% for Q2 2026, down 553.0% year-over-year from 15.81% in Q2 2025, and down 2.34% quarter-over-quarter from 73.32% in Q1 2026.
Biogen (BIIB) Gross Margin (2009 - 2026) Analysis & Trends
Biogen's Gross Margin history runs 18 years deep, the most recent figure standing at 71.6% for Q2 2026.
- In Q2 2026, Gross Margin fell 553.0% year-over-year to 71.6%; the TTM figure through Jun 2026 stood at 73.99% (down 143.0% YoY), while the FY2025 annual figure was 75.69%, down 43.0% from the prior year.
- Gross Margin for Q2 2026 stood at 71.6%, down from 73.32% in the prior quarter.
- The five-year high for Gross Margin was 93.55% in Q4 2022, with the low at 71.6% in Q2 2026.
- The 5-year median for Gross Margin is 76.28% (2024), against an average of 78.53%.
- The sharpest annual moves came in 2022 and 2024: Gross Margin surged 689 bps in 2022, then tumbled 1690 bps in 2024.
- Biogen's Gross Margin stood at 93.55% in 2022, then retreated by 0 bps to 93.13% in 2023, then declined by 18 bps to 76.23% in 2024, then grew by 3 bps to 78.26% in 2025, then fell by 9 bps to 71.6% in 2026.
- Business Quant data shows BIIB's Gross Margin at 71.6% in Q2 2026, 73.32% in Q1 2026, and 78.26% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.91 Bn | 632.15 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 469.40 Bn | 462.83 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 375.75 Bn | 368.61 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 303.13 Bn | 295.44 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.65 Bn | 252.75 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 236.26 Bn | 222.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 182.12 Bn | 178.95 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 159.46 Bn | 147.76 Bn | 10.94 Bn | 72.78% |
| 9 | Gsk | 106.21 Bn | 102.04 Bn | 8.24 Bn | 73.05% |
| 10 | Biogen | 32.12 Bn | 30.84 Bn | 1.96 Bn | 71.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.60% |
| Mar 31, 2026 | 73.32% |
| Dec 31, 2025 | 78.26% |
| Sep 30, 2025 | 73.39% |
| Jun 30, 2025 | 77.13% |
| Mar 31, 2025 | 74.11% |
| Dec 31, 2024 | 76.23% |
| Sep 30, 2024 | 74.10% |
| Jun 30, 2024 | 77.85% |
| Mar 31, 2024 | 76.33% |
| Dec 31, 2023 | 93.13% |
| Sep 30, 2023 | 73.93% |
| Jun 30, 2023 | 75.87% |
| Mar 31, 2023 | 73.09% |
| Dec 31, 2022 | 93.55% |
| Sep 30, 2022 | 81.28% |
| Jun 30, 2022 | 81.31% |
| Mar 31, 2022 | 89.14% |
| Dec 31, 2021 | 94.00% |
| Sep 30, 2021 | 81.58% |